AlloVir (ALVR)
(Delayed Data from NSDQ)
$0.79 USD
-0.03 (-4.01%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $0.78 -0.01 (-0.70%) 7:58 PM ET
2-Buy of 5 2
D Value A Growth F Momentum C VGM
AlloVir, Inc. (ALVR) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$0.98 | $1.50 | $0.50 | 19.51% |
Price Target
Based on short-term price targets offered by four analysts, the average price target for AlloVir, Inc. comes to $0.98. The forecasts range from a low of $0.50 to a high of $1.50. The average price target represents an increase of 19.51% from the last closing price of $0.82.
Analyst Price Targets (4 )
Broker Rating
AlloVir, Inc. currently has an average brokerage recommendation (ABR) of 3.42 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by four brokerage firms. The current ABR compares to an ABR of 3.42 a month ago based on four recommendations.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 0 | 0 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 2 | 2 | 2 | 2 | 2 |
Sell | 2 | 2 | 2 | 2 | 2 |
Strong Sell | 0 | 0 | 0 | 1 | 1 |
ABR | 3.42 | 3.42 | 3.42 | 3.74 | 3.74 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
9/13/2024 | Piper Sandler | Christopher Raymond | Hold | Hold |
7/11/2024 | SVB Securities | Mani Foroohar | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 3.42 |
ABR (Last week) | 3.42 |
# of Recs in ABR | 4 |
Average Target Price | $0.98 |
LT Growth Rate | 29.50% |
Industry | Medical - Drugs |
Industry Rank by ABR | 89 of 252 |
Current Quarter EPS Est: | -0.10 |
ALVR FAQs
AlloVir, Inc. (ALVR) currently has an average brokerage recommendation (ABR) of 3.42 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 4 brokerage firms.
The average price target for AlloVir, Inc. (ALVR) is $.98. The current on short-term price targets is based on 1 reports.
The forecasts for AlloVir, Inc. (ALVR) range from a low of $.5 to a high of $1.5. The average price target represents a increase of $24.05 from the last closing price of $.79.
The current UPSIDE for AlloVir, Inc. (ALVR) is 24.05%
Based on short-term price targets offered by four analysts, the average price target for AlloVir, Inc. comes to $0.98. The forecasts range from a low of $0.50 to a high of $1.50. The average price target represents an increase of 19.51% from the last closing price of $0.82.